Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032
New York, USA, June 04, 2025 (GLOBE NEWSWIRE) — Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight
The AI in remote patient monitoring market is witnessing strong growth, driven by the increasing prevalence of chronic illnesses like cancer, cardiovascular conditions, and lifestyle-related disorders. This momentum is further boosted by a rise in product innovation, growing global investments in digital health infrastructure, and a heightened focus on proactive, data-centric healthcare approaches. These trends are anticipated to significantly accelerate the expansion of the AI-enabled RPM market throughout the forecast period of 2025 to 2032.
DelveInsight's AI in Remote Patient Monitoring Market Insights report provides the current and forecast market analysis, individual leading AI in remote patient monitoring companies' market shares, challenges, AI in remote patient monitoring market drivers, barriers, trends, and key market AI in remote patient monitoring companies in the market.
Key Takeaways from the AI in Remote Patient Monitoring Market Report As per DelveInsight estimates, North America is anticipated to dominate the global AI in remote patient monitoring market during the forecast period.
In the product type segment of the AI in remote patient monitoring market, the devices category held the largest revenue share in 2024.
Notable AI in remote patient monitoring companies such as Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., AliveCor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, and several others are currently operating in the AI in remote patient monitoring market.
and several others are currently operating in the AI in remote patient monitoring market. In September 2024, iRhythm Technologies announced the Japanese regulatory approval of the zio® ECG monitoring system, the first product to deliver arrhythmia monitoring service utilizing artificial intelligence.
announced the Japanese regulatory approval of the zio® ECG monitoring system, the first product to deliver arrhythmia monitoring service utilizing artificial intelligence. In April 2024, Royal Philips, a global leader in health technology, announced a strategic partnership to integrate smartQare's advanced solution, viQtor, with Philips' world-leading clinical patient monitoring platforms. This collaboration aims to enable the next generation of continuous patient monitoring both in and out of the hospital, starting in Europe.
To read more about the latest highlights related to the AI in remote patient monitoring market, get a snapshot of the key highlights entailed in the Global AI in Remote Patient Monitoring Market Report
AI in Remote Patient Monitoring Overview
Artificial intelligence (AI) is revolutionizing remote patient monitoring (RPM) by enabling real-time, continuous health surveillance outside of traditional clinical settings. Through wearable devices and connected sensors, AI algorithms can analyze vital signs, detect anomalies, and predict potential health deterioration before symptoms become critical. This proactive approach allows for early interventions, reduces hospital readmissions, and improves chronic disease management, particularly for conditions like heart failure, diabetes, and COPD. By automating data analysis and triage, AI also significantly reduces the burden on healthcare professionals, allowing them to focus on patients who need urgent attention.
Furthermore, AI-driven RPM fosters personalized care by learning from individual patient data over time. Machine learning models can adapt to each patient's unique health patterns, improving the accuracy of predictions and enabling tailored treatment plans. Natural language processing (NLP) tools can also interpret patient-reported symptoms via apps or voice interfaces, enriching the clinical picture. As AI technologies evolve, their integration into RPM systems is expected to enhance accessibility, especially in rural or underserved areas, bridging gaps in healthcare delivery while maintaining cost-efficiency and high-quality care.
AI in Remote Patient Monitoring Market Insights
North America is projected to lead the AI in remote patient monitoring market from 2025 to 2032. This dominance is largely driven by factors such as the growing prevalence of chronic diseases like cancer, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government initiatives. The region also benefits from significant investments in digital health and the extensive use of wearable and connected medical devices.
The rising incidence of cancer in the U.S. and Canada is fueling the demand for continuous, home-based care solutions. This trend is accelerating the adoption of AI-driven remote patient monitoring, which enhances treatment management, symptom tracking, and patient outcomes outside traditional healthcare settings.
Additionally, the increasing rates of cardiovascular diseases and related risk factors are heightening the need for ongoing and efficient monitoring solutions. AI-powered remote monitoring enables early detection, real-time intervention, and personalized care for heart patients, particularly in aging populations, thereby reducing complications and improving outcomes.
Together, these factors create a favorable landscape for market expansion, solidifying North America's position as the leading region in the AI-based remote patient monitoring market throughout the forecast period.
To know more about why North America is leading the market growth in the AI in remote patient monitoring market, get a snapshot of the AI in Remote Patient Monitoring Market Outlook
AI in Remote Patient Monitoring Market Dynamics
The AI in remote patient monitoring market is undergoing rapid transformation, driven by the convergence of advanced technologies, shifting healthcare models, and an increasing emphasis on personalized care. Artificial Intelligence is enhancing RPM systems by enabling real-time data analysis, predictive analytics, and automation, thereby helping providers manage chronic diseases, post-operative care, and elderly patients more effectively. AI algorithms can analyze vast volumes of patient data from wearable devices and home-based monitoring systems, identifying anomalies and alerting care teams before a crisis occurs. This proactive capability is fueling demand, particularly in value-based care models where preventing hospital readmissions is key.
One of the primary drivers of this market is the global increase in chronic diseases and aging populations, which has led to an urgent need for continuous and cost-effective patient monitoring. AI-based RPM solutions not only reduce the burden on healthcare systems but also empower patients to manage their conditions better. Furthermore, the COVID-19 pandemic accelerated adoption, normalizing virtual care and remote diagnostics. This shift has continued post-pandemic, with healthcare providers and payers increasingly investing in AI-driven tools to support hybrid care models and decentralize service delivery.
However, the market is not without its challenges. Data privacy, regulatory hurdles, and interoperability issues are key barriers to widespread adoption. The effectiveness of AI algorithms depends heavily on access to high-quality, diverse datasets, and data silos across healthcare institutions can limit this. Additionally, regulatory frameworks are still evolving to keep pace with AI's rapid advancement, and there's ongoing scrutiny about algorithmic bias and accountability. Addressing these challenges is crucial for building trust among clinicians and patients alike.
On the competitive front, the market is witnessing intense innovation and strategic partnerships among tech firms, medtech companies, and healthcare providers. Startups are emerging with specialized AI capabilities in areas like arrhythmia detection, diabetic monitoring, and mental health assessment, while major players are integrating AI into their existing RPM platforms. Cloud infrastructure providers and AI-as-a-service vendors are also playing a key role in scaling solutions across geographies.
Looking ahead, the AI in RPM market is expected to experience sustained growth, driven by advances in sensor technology, 5G connectivity, and federated learning models that allow privacy-preserving data sharing. As AI becomes more explainable and transparent, its integration into clinical workflows will deepen, making remote monitoring an integral part of mainstream healthcare delivery.
Get a sneak peek at the AI in remote patient monitoring market dynamics @ AI in Remote Patient Monitoring Market Dynamic Analysis Report Metrics Details Coverage Global Study Period 2022–2032 AI in Remote Patient Monitoring Market CAGR ~27% AI in Remote Patient Monitoring Market Size by 2032 USD 13.1 Billion Key AI in Remote Patient Monitoring Companies Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., AliveCor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, among others
AI in Remote Patient Monitoring Market Assessment AI in Remote Patient Monitoring Market Segmentation AI in Remote Patient Monitoring Market Segmentation By Product Type: Devices, Software, and Services AI in Remote Patient Monitoring Market Segmentation By Application: Cancer, Cardiovascular Disorder, Lifestyle Disorders, and Others AI in Remote Patient Monitoring Market Segmentation By End User: Hospitals and Clinics, Diagnostic Centers, and Homecare Setting AI in Remote Patient Monitoring Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the AI in remote patient monitoring market are set to emerge as the trendsetter explore @ AI in Remote Patient Monitoring Companies
Table of Contents 1 AI in Remote Patient Monitoring Market Report Introduction 2 AI in Remote Patient Monitoring Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 AI in Remote Patient Monitoring Market Key Factors Analysis 6 AI in Remote Patient Monitoring Market Porter's Five Forces Analysis 7 AI in Remote Patient Monitoring Market Layout 8 AI in Remote Patient Monitoring Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us
Interested in knowing the AI in remote patient monitoring market by 2032? Click to get a snapshot of the AI in Remote Patient Monitoring Market Trends
Related Reports
Patient Monitoring Devices Market
Patient Monitoring Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key patient monitoring devices companies, including Medtronic plc, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, among others.
Artificial Intelligence in Drug Commercialization Market
Artificial Intelligence in Drug Commercialization Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in drug commercialization companies, including EVERSANA, Lyfegen, Syneos Health, McKinsey & Company, ICON plc., Clarivate., Thermo Fisher Scientific Inc., Viseven, ZS Associates, Cloud Pharmaceuticals Inc., among others.
Artificial Intelligence in Precision Medicine Market
Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others.
Artificial Intelligence In Drug Discovery Market
Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others.
Artificial Intelligence in Medical Imaging Market
Artificial Intelligence in Medical Imaging Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in medical imaging companies, including Microsoft, Siemens Healthineers, GE Healthcare, NVIDIA Corporation, Philips Healthcare, Arterys, Butterfly Network, Enlitic, HeartFlow, Digital Diagnostics, among others.
DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Secure Access Service Edge (SASE) Market Outlook 2025-2030: Compliance with GDPR, HIPAA, and Other Regulations Drives Adoption with Industry Registering 23.6% CAGR
Secure Access Service Edge (SASE) Market Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Secure Access Service Edge (SASE) Market by Offering (SD-WAN, SSE), SD-WAN Offering (Software, Appliances), SSE Offering (Zero Trust Network Access, Cloud Access Security Broker, Secure Web Gateway, Firewall as a Service) - Global Forecast to 2030" report has been added to SASE market is estimated to be USD 15.52 billion in 2025 and reach USD 44.68 billion in 2030 at a CAGR of 23.6%, from 2025 to 2030. Regulatory mandates such as GDPR, HIPAA, and others mandate are pushing organizations have in place measures for data access, usage, and protection. This involves having sensitive data available only to authenticated users, logging all access activity, and having detailed audit logs. SASE facilitates these compliance initiatives by offering a centralized platform that enforces uniform security policies on all users, locations, and devices. With built-in logging, data loss prevention (DLP), and identity-based access controls, SASE allows organizations to prove compliance, minimize the risk of a violation, and quickly respond to audits or an incident involving sensitive data. Zero Trust Network Access SSE Solutions to contribute the largest share of the SASE market during the forecast periodZTNA is a security architecture that enforces strong identity authentication and access controls before allowing users access to applications or data, whether they are remote or on-premises. In contrast to legacy VPNs, ZTNA adheres to the never trust, always verify principle, dynamically verifying user identity, device posture, and context with each access request. It employs safe, encrypted tunnels to connect users solely to the precise resources to which they have permission to connect, without exposing the wider network. ZTNA solutions are generally combined with identity providers, endpoint detection software, and policy engines to continually evaluate risk and enforce detailed, least-privilege access. This reduces the attack surface, stops lateral movement, and enhances visibility across user activity, and thus forms a central element of contemporary, cloud-native security designs. SD-WAN Appliances projected to register the highest CAGR during the forecast periodSD-WAN appliances are physical or virtual devices that are installed at network edge locations like branch offices or data centers to direct and control traffic over various kinds of connections like MPLS, broadband, and LTE. These appliances facilitate smart path selection, application-aware routing, and centralized policy enforcement to enable businesses to optimize performance, minimize latency, and enhance reliability for mission-critical applications. They tend to include security functionalities like firewalls, encryption, and intrusion prevention, and enable secure and effective connectivity. SD-WAN appliances are also easier to deploy and scale, making them perfect for organizations with distributed operations. With features such as real-time analytics, automated failover, and cloud integration, the appliances provide efficient performance and seamless user experiences across the America projected to have the largest market share during the forecast periodThe SASE market in North America is growing rapidly, fueled by the increasing demand for cloud-based security technologies and the shift toward remote work. Organizations are increasingly embracing SASE to better secure their networks, streamline network management, and provide remote workers and distributed teams with seamless, secure access. Key market players include Cisco Systems, Palo Alto Networks, Zscaler, Fortinet, and Akamai Technologies, which are driving the market with advanced solutions that combine network security and connectivity. The region is witnessing increased investment in cybersecurity infrastructure, with companies prioritizing solutions that offer scalability, flexibility, and strong protection across their transition is pushing businesses to transform their security practices, integrating SASE to accelerate digital transformation and meet the evolving needs of a hybrid workforce. As the market expands, companies also focus on improving their understanding of network traffic and enhancing threat detection to respond effectively to real-time security incidents. The growing sophistication of cyberattacks is further driving the demand for unified, cloud-native security platforms like SASE. Research CoverageThe market study covers the SASE market size across different segments. It aims to estimate the market size and the growth potential across different segments, including offering (infrastructure, services), business model, and regions. The study includes an in-depth competitive analysis of the leading market players, their company profiles, key observations related to product and business offerings, recent developments, and market strategies. The major players in the SASE market are Cisco Systems (US), HPE (US), Verizon (US), Broadcom (US), Fortinet (US), Akamai (US), Oracle (US), Juniper Networks (US), Extreme Networks (US), AT&T (US), Palo Alto (US), Checkpoint Software Technologies (Israel), and Huawei (China). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, product enhancements, and acquisitions to expand their footprint in the SASE Attributes Report Attribute Details No. of Pages 369 Forecast Period 2025-2030 Estimated Market Value (USD) in 2025 $15.52 Billion Forecasted Market Value (USD) by 2030 $44.68 Billion Compound Annual Growth Rate 23.6% Regions Covered Global Key Topics Covered Market Dynamics Drivers Rising Adoption of Remote Work and Hybrid Workforce Models Zero Trust Security Implementation Growing SD-WAN Adoption Restraints High Implementation Costs Complexity in Migrating from Legacy Infrastructure to SASE Opportunities Growing Digital Transformation Initiatives Across Industries Expansion of Edge Computing and 5G Networks Challenges Managing Multi-Cloud and Hybrid Environments Ensuring Data Sovereignty and Compliance Ecosystem Analysis Case Study Analysis Lemonade Insurance Innovates Secure Work Access with Prisma Access Browser European Software Company Cuts Cybersecurity Costs by 50% with Fortinet's FortiSASE for Hybrid Workforce Security SASE Provides Manufacturing Company with Foundation for Secure Future Strengthening Solar Energy Networks with Versa Unified SASE Through SB Energy's Security Journey Value Chain Analysis Tariff and Regulatory Landscape Pricing Analysis Average Selling Prices Offered by Key Players, by SSE Offering, 2024 Indicative Pricing Offered Key Players, by SASE Offering, 2024 Technology Analysis Key Technologies Virtualization Cloud Computing Complementary Technologies Data Analytics Virtual Private Networks Adjacent Technologies Artificial Intelligence & Machine Learning 5G and Next-Generation Networks IoT Edge Computing Patent Analysis Porter's Five Forces Analysis Trends/Disruptions Impacting Customer Business Key Stakeholders and Buying Criteria Key Conferences and Events, 2025-2026 Technology Roadmap for SASE Market Best Practices to Implement in SASE Current and Emerging Business Models Tools, Frameworks, and Techniques Trade Analysis Impact of AI/Gen AI on SASE Market Investment and Funding Scenario Impact of 2025 US Tariffs: SASE Market Introduction Key Tariff Rates Price Impact Analysis Key Impact on Various Regions North America Europe Asia-Pacific End-Use Industry Impact Manufacturing Financial Services Healthcare Retail and E-Commerce Education Companies Profiled in this SASE Market Report Cisco Systems Broadcom Palo Alto Networks Akamai Fortinet Hewlett Packard Enterprise (HPE) Huawei AT&T Verizon Juniper Networks Oracle Nokia Extreme Networks, Inc. Check Point Software Technologies Orange Business Comcast Corporation Ericsson BT Group Barracuda Networks Sophos Riverbed Technology Zain Group Lumen Technologies KT Corporation Colt Technology Services NEC Corporation Tata Communications Forcepoint Kyndryl GTT Communications NTT Communications STC Deutsche Telekom Telefonica Telstra Vodafone Group HCL Tech Microland Wipro Singtel Zscaler Netskope Cloudflare McAfee Tibco Software Proofpoint Sonicwall Versa Networks Aryaka Networks Cato Networks Flexiwan Nour Global Fatpipe Networks Lavelle Networks Peplink MCM Telecom Ransnet Open Systems Exium Twingate Claro Enterprise Solutions Nordlayer For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Secure Access Service Edge (SASE) Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
20 minutes ago
- Business Wire
AVI Calls for Changes at Gerresheimer
LONDON--(BUSINESS WIRE)--Asset Value Investors ('AVI') has sent an open letter to the Supervisory Board of Gerresheimer AG ('Gerresheimer') calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth prospects. These have been reaffirmed in 2025 with reports of private equity interest in Gerresheimer. This value is not currently reflected in its shares, which trade at a substantial discount to their sum-of-the-parts. The shares now sit some -56% below their 52-week high. Shareholder value is at risk. AVI believes that: New financial leadership is required to repair the relationship with the market and restore credibility. Gerresheimer should establish a capital allocation committee to oversee and review the Company's capital allocation and capital structure. Gerresheimer should look to exit Moulded Glass. Time is of the essence and a new and improved plan for Gerresheimer should be presented at a capital markets day later this year. Joe Bauernfreund, CEO and CIO of AVI, commented: 'Gerresheimer is a leading player in the Containment Solutions and Delivery Systems industry, which offers attractive growth. We believe that Gerresheimer should benefit from this. 'We understand the market's scepticism surrounding Gerresheimer and we believe that these steps are the key to unlocking value and repairing its relationship with the market.' Wilfrid Craigie, Senior Investment Analyst at AVI, added: 'Despite the strategic transformation to move Gerresheimer higher up the value chain, we believe that the market is assigning Gerresheimer a large discount, leading to its current valuation. 'We believe that Gerresheimer's current valuation is being dragged down by Moulded Glass, and the best way to improve its financial profile and valuation is to perform a swift strategic review to exit it.' About Asset Value Investors: AVI is an investment management company established in London, United Kingdom, in 1985. AVI has invested in Global and Japanese equities for nearly 40 years. AVI manages AVI Global Trust plc ("AGT"), AVI Japan Opportunity Trust plc ("AJOT"), and MIGO Opportunities Trust ("MIGO"). AGT, AJOT, MIGO are public companies whose shares are listed and traded on the main market of the London Stock Exchange.
Yahoo
20 minutes ago
- Yahoo
AVI Calls for Changes at Gerresheimer
LONDON, June 06, 2025--(BUSINESS WIRE)--Asset Value Investors ("AVI") has sent an open letter to the Supervisory Board of Gerresheimer AG ("Gerresheimer") calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth prospects. These have been reaffirmed in 2025 with reports of private equity interest in Gerresheimer. This value is not currently reflected in its shares, which trade at a substantial discount to their sum-of-the-parts. The shares now sit some -56% below their 52-week high. Shareholder value is at risk. AVI believes that: New financial leadership is required to repair the relationship with the market and restore credibility. Gerresheimer should establish a capital allocation committee to oversee and review the Company's capital allocation and capital structure. Gerresheimer should look to exit Moulded Glass. Time is of the essence and a new and improved plan for Gerresheimer should be presented at a capital markets day later this year. Joe Bauernfreund, CEO and CIO of AVI, commented: "Gerresheimer is a leading player in the Containment Solutions and Delivery Systems industry, which offers attractive growth. We believe that Gerresheimer should benefit from this. "We understand the market's scepticism surrounding Gerresheimer and we believe that these steps are the key to unlocking value and repairing its relationship with the market." Wilfrid Craigie, Senior Investment Analyst at AVI, added: "Despite the strategic transformation to move Gerresheimer higher up the value chain, we believe that the market is assigning Gerresheimer a large discount, leading to its current valuation. "We believe that Gerresheimer's current valuation is being dragged down by Moulded Glass, and the best way to improve its financial profile and valuation is to perform a swift strategic review to exit it." About Asset Value Investors: AVI is an investment management company established in London, United Kingdom, in 1985. AVI has invested in Global and Japanese equities for nearly 40 years. AVI manages AVI Global Trust plc ("AGT"), AVI Japan Opportunity Trust plc ("AJOT"), and MIGO Opportunities Trust ("MIGO"). AGT, AJOT, MIGO are public companies whose shares are listed and traded on the main market of the London Stock Exchange. View source version on Contacts Quill PR - AVI@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
